Star-shaped polypeptides
Partner with us to speed up the development of SNAPP anti-bacterial technology. Explore opportunities for licensing or direct investment.
The technology
University of Melbourne researchers have created star-shaped polypeptides. These are Structurally Nanoengineered Antimicrobial Peptide Polymers, or SNAPPs. They have anti-bacterial properties, including against MDR bacteria.
SNAPPs also have adjuvant activity, improving the efficiency of existing antibiotics.
Market need
Multi-drug resistant (MDR) bacteria are a threat to human health. The development of novel anti-bacterial therapies is a global health priority.
Technology status
Proof-of-concept has been achieved using various in vitro microscopy and bioassay studies. These show SNAPPs’ antimicrobial activity, mode of action and low toxicity.
- Contact
- Shereen Tan
- tan.s@unimelb.edu.au
- +61 3 9035 6020
Banner image: Multi-drug resistant (MDR) bacteria are a threat to human health. Image: Medical illustration of drug-resistant, Neisseria gonorrhoeae bacteria. Photo by US Centers for Disease Control and Prevention (CDC) on Unsplash.
First published on 10 September 2024.
Share this article
Research commercialisation opportunitiesResearch Innovation and Commercialisation
Keep reading
-
CCL17
Recently licensed: A company has partnered with us to develop a new pain treatment technology that blocks CCL17 expression.
-
Plasmonic pixel
Partner with us to speed up the adoption of the multispectral plasmonic pixel. Talk to us about licensing or direct investment.
-
Predicting landslides
New open-pit mining technology can predict landslides up to 15 days in advance.
-
Severe asthma therapy
Recently licensed: A start-up has partnered with us to accelerate the development of a therapy for steroid-resistant asthma.